A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Aker BioMarine

Company-logo  COMPANY DETAILS
Aker BioMarine
Oksenøyvn. 10 (Bygg B)
1366 Lysaker
Norway


Website
Website
Mail
Call
  +47 24 13 00 10


HEALTH CATEGORIES

cardiovascular health; general health and wellness; nutraceuticals; stress and inflammation; supplements



Aker BioMarine is a vertically integrated biotechnology company and the world’s leading supplier of krill-derived biotech products. The company is supplying krill marine ingredients through an optimized value chain from raw materials to customer.

Aker BioMarine utilizes its unique krill harvesting methods to develop its own downstream operations within the high value added nutraceutical and aquaculture feed markets.

Krill derived products, such as krill oil and meal, have a high content of bioactive ingredients, e.g. Omega-3 bound phospholipids, choline and astaxanthin, which have documented positive effects on both humans and animals.

Superba KrillTM is the company’s krill oil nutraceutical line for humans and QrillTM covers all krill meal products for both the aquaculture and pet food markets.

Superba Krill is the world’s most researched krill oil brand. The naturally occurring nutrients in krill oil offer many benefits supporting the heart, liver, brain, skin and joints, allowing for optimal end product differentiation by brand owners.

Aker BioMarine has a wide set of capabilities within nutraceuticals (dietary supplements and functional foods) and is an experienced player in nutraceutical applications of lipids, product development, and intellectual property rights (IPR), R&D and product commercialization.



Articles On NutritionInsight
FormattedPicture

NUTRITION & HEALTH NEWS

Noventure lands license agreement for high-purity omega 3 supplement with Azur

18 Feb 2021 --- Spain-based Noventure has signed an exclusivity agreement with Azur – a division of Solutex – for the licensing rights of EPA3G, a patented emulsion of high-purity... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Aker BioMarine reports 17% revenue growth in 2020 amid krill EPA/DHA launch and COVID-19 hurdles

16 Feb 2021 --- Aker BioMarine saw steady growth during 2020, as announced in the year’s Q4 financial results. Revenue growth reached 17 percent for the full year, translating into US$289... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Aker BioMarine launches krill protein isolate for sustainable F&B

14 Jan 2021 --- Aker BioMarine is tapping into the global demand for non-dairy and non-soy protein with the launch of Invi, a hydrolyzed krill protein isolate for powders, foods and beverages. Invi... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Aker BioMarine’s new venture to advance Lysoveta for brain and eye pharmaceuticals

11 Jan 2021 --- Aker BioMarine has teamed up with Medical Food Solutions Research to develop its lysophosphatidylcholine (LPC)-bound EPA and DHA ingredient Lysoveta into pharmaceutical therapies.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Aker BioMarine scores first US university partnership on LPC-bound EPA and DHA

07 Jan 2021 --- Aker BioMarine has obtained exclusive rights to the University of Illinois Chicago’s (UIC) intellectual property related to lysophosphatidylcholine (LPC), being researched for... Read More




Videos
FormattedPicture

New krill oil market potential

14 May 2019 --- Aker BioMarine is a biotech innovator and the world’s leading supplier of krill-based ingredients. Superba Krill oil is a 100 percent pure Antarctic krill oil and the only krill oil brand to have 4 EU authorized health claims. Krill oil contains omega-3 EPA & DHA, phospholipids, choline and astaxanthin. These naturally occurring nutrients make krill oil unique and unmatched in the omega-3 space. At Vitafoods Europe 2019, the company presented various possibilities with Superba krill oil. CEO, Matts Johansen, discusses how the market for krill oil is developing. 

FormattedPicture

Market Opportunities in Krill Oil

18 May 2017 --- Aker BioMarine recently reported how the company managed to grow sales and improve operations in the still-challenging omega-3 market, and continues to heavily invest in new technology and the development of new krill-derived products. Matts Johansen, CEO of Aker BioMarine, is satisfied with the result, but admitted that 2016 was still a challenging year for the company. Johansen said. “Although 2016 was a good year for Aker BioMarine, we posted slightly negative earnings after tax. The investments needed to build a supply chain for krill-based products, the resources needed to innovate and document their biological effects, and the time needed to develop new markets are reflected in our earnings.”




Articles On The World of Food Ingredients
FormattedPicture

THE WORLD OF FOOD INGREDIENTS

View From The Top: Matts Johansen, CEO, Aker BioMarine

01 Aug 2016 --- Aker BioMarine, the leading supplier of krill-derived products, ramped up its investment in R&D in 2015. Of the company’s turnover of $US105 million, $US20 million was reinvested into enabling technologies and the scientific support behind them.

FormattedPicture

THE WORLD OF FOOD INGREDIENTS

Opinion Edge – The Right Personal Nutrition Approach

05 Aug 2015 --- Key suppliers offer their thoughts on the trends that will drive the nutritionals market forward. What is the future for personalized nutrition and which condition specific nutrition areas are on-trend?




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W